Аңдатпа
3.1-9.1)inthe discontinuation group (Disc-Group)(p¼.008).The rate of thromboembolic events in the Con-Group was2.1% (95%CI 0.3-3.9) in comparison to 7.7% (95% CI 4.4-11.0)intheDisc-Group(p¼.006).Conclusion: Continuation of ASA in elective cranial procedures seems to be safe and to provide protection from thromboembolic complications.Therefore, in patients under ASA for secondary prevention, perioperative treatment continuation seems advisable.